Drugs for underactive bladder are limited and often cause side effects. That's why neuromodulation — using electrical pulses to stimulate nerves — is exploding. The underactive bladder market research shows that neuromodulation devices are the fastest‑growing category, with a CAGR above 8%. Why? Because they're effective, reversible, and don't require daily pills.
What's available? Implantable sacral neuromodulators (like Medtronic's InterStim) and non‑implantable PTNS (needle in the ankle). The underactive bladder market trends highlight that the fastest‑growing end‑user segment is homecare settings, as patients manage PTNS at home after initial training.
But neuromodulation is expensive — InterStim costs $20k‑$30k for the implant plus surgery. And not all insurers cover it. Still, for patients who've failed medications, it's a game‑changer.
The bottom line: if you've tried drugs and still can't empty your bladder, ask about neuromodulation. It's not for everyone, but it could give you your life back.
